624. Hodgkin Lymphomas: Clinical and Epidemiological: Poster III

Reduced pulmonary function and posterior cerebral artery perfusion among Hodgkin lymphoma survivors

Targeted immunotherapy in children adolescents and young adults CAYA with newly diagnosed classical Hodgkin lymphoma A single center experience

Brentuximab vedotin Bv AVD efficacy is influenced by interim PET age ECOG performance status and CIRS g in previously untreated patients with stage IV classical Hodgkin lymphoma An Italian real life multicentric study

Pembro CORE Interim analysis of a phase II PET adapted trial omitting high dose chemotherapy with PD 1 based salvage in first relapsed Hodgkin lymphoma

Nivolumab and pembrolizumab in treatment of relapsed or refractory classical Hodgkin lymphoma Systematic review and meta analysis of clinical trials

A national cancer database study of survival trends in patients with classical Hodgkin lymphoma Improved survival in the novel agent era

Comparable survival with transplant free approach versus autologous stem cell transplantation in adult relapsed refractory classic Hodgkin lymphoma achieving complete remission

Curable but not equal Survival disparities in classic Hodgkin lymphoma by treatment facility type in the United States

Real world outcomes of immune checkpoint inhibitor rechallenge in patients with classical Hodgkin lymphoma